A 2025 systematic review in the International Journal of Dermatology documented liver function abnormalities in approximately half of IV-treated participants at high doses, which is why DermaVue restricts treatment to evidence-based clinical doses of 400 to 1200 mg with mandatory hepatic monitoring
Understanding how these treatments affect digestion, recognising personal triggers, and making suitable lifestyle adjustments can help reduce discomfort while continuing your weight management plan
Thymosins in multiple sclerosis and its experimental models: Moving from basic to clinical application
If you have commercial insurance coverage for the Wegovy pill, you can get a one-month Rx for as low as $25 per month with the Wegovy-specific manufacturer savings offer
One of the most meaningful clinical trial results of 2026 was announced today, and it involves children
The result is a lightweight, stable powder that is ideal for long-term storage